India, April 4 -- Alcon, the global leader in eye care, has announced the launch of wavelight plus, India's first fully personalised Laser-Assisted In Situ Keratomileusis (LASIK) treatment.

Alcon is a leader in refractive vision correction and its next-generation wavelight plus technology introduces a new era of precision in refractive surgery, with unprecedented levels of personalisation offering patients outstanding visual outcomes with minimal risk and excellent predictability.Wavelight plus has received Central Drugs Standard Control Organisation (CDSCO) India approval, CE Mark and recently received US Food and Drug Administration (FDA) approval.

Myopia is the most common refractive error, and globally, more than 30% of the populati...